Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. G. P. Vandaele, P. Schelstraete, F. Haerynck, H. Franckx, G. Claeys, M. Vaneechoutte, F. De Baets (Gent, De Haan, Belgium). Pseudomonas aeruginosa DNA-fingerprinting of colonized CF-patients in a rehabilitation centre: a 2-years survey. Eur Respir J 2003; 22: Suppl. 45, 1132

Member's Comments

No comment yet.

Related content which might interest you: Pseudomonas aeruginosa DNA-fingerprinting register in Belgian CF-patients: a one year survey Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre Source: Eur Respir J, 53 (4) 1802081; 10.1183/13993003.02081-2018 Year: 2019 Dental units as infection sources of Pseudomonas aeruginosa Source: Eur Respir J 2008; 32: 1122-1123 Year: 2008 DNA fingerprinting of Pseudomonas aeruginosa (Pa) in cystic fibrosis patients: risk assessment of cross-colonisation in a CF revalidation centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Prognosis of Acinetobacter baumannii bacteraemia in a respiratory ICU: 10 years‘ experience Source: Eur Respir J 2005; 26: Suppl. 49, 222s Year: 2005 The mortality of Acinetobacter baumanni infection in intensive care unit Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia Source: Eur Respir J 2007; 29: 548-560 Year: 2007 Acinetobacter baumani and Pseudomonas aeruginosa drug susceptibility after bacteriological analysis of sputum in patients mechanically ventilated in ICU Source: Eur Respir J 2003; 22: Suppl. 45, 450s Year: 2003 Does a single Pseudomonas aeruginosa isolation predict COPD mortality? Source: Eur Respir J 2014; 44: 794-797 Year: 2014 The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018 Pseudomonas aeruginosa and legionella pneumophilia in water of dental units Source: Eur Respir J 2006; 28: Suppl. 50, 486s Year: 2006 Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006 Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?> Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep? Year: 2017 Acinetobacter baumannii infection and colonization among pediatric patients in pediatric ICU and other ICUs Source: International Congress 2018 – Neonatology and paediatric intensive care Year: 2018 Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults. Source: International Congress 2017 – New insights into paediatric respiratory infections Year: 2017 A prospective controlled study of azithromycin on lower respiratory tract infections caused by multi-drug resistant Pseudomonas aeruginosa in the elderly in intensive care unit Source: Eur Respir J 2005; 26: Suppl. 49, 187s Year: 2005 Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty? Source: Eur Respir J 2010; 35: 473-474 Year: 2010 The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012